Akromegali hastalarında Growth hormon ve insülin like growth faktör-1 düzeyi ile aterosklerotik risk belirteçleri arasındaki ilişki
Abstract
Keywords
References
- 1.Melmed S. Medical progress: Acromegaly. N Engl JMed 2006; 355: 2558.
- 2.Fernandez A, Karavitaki N, Wass JA. Prevalence ofpituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). ClinEndocrinol (Oxf) 2010; 72: 377.
- 3. Dekkers OM, Biermasz NR, Vandenbroucke, J. et al.Mortality in acromegaly: a metaanalysis. J ClinEndocrinol Metab 2008; 93(1): 61-7.
- 4.Mosca S, Paolillo S, Colao A. et al. Cardiovascularinvolvement in patients affected by acromegaly: anappraisal. Int J Cardiol 2013; 167(5): 1712 8.
- 5.Pivonello R, Auriemma RS, Grasso LF, et al.Complications of acromegaly: cardiovascular,respiratory and metabolic comorbidities. Pituitary2017; 2081):46-62.
- 6.Topaloglu O, Sayki Arslan M, Turak O, et al. "Threenoninvasive methods in the evaluation of subclinicalcardiovascular disease in patients with acromegaly:epicardial fat thickness, aortic stiffness and serumcell adhesion molecules." Clinical endocrinology2014;80(5): 726-34.
- 7.Colao A, Spiezia S, Cerbone G, et al. Increased arterial intima‐media thickness by B‐M modeechodoppler ultraso-nography in acromegaly.Clinical endocrinology 2001; 54(4): 515-24.
- 8.Piskinpasa H, Okuturlar Y, Sadri S, et al. VisfatinLevels May be an Early Marker of Atherosclerosis inPatients with Acromegaly. Horm Metab Res. 2019Oct;51(10):649-654. doi: 10.1055/a-0998-4079.Epub 2019 Sep 5.
Details
Primary Language
Turkish
Subjects
Medical Education
Journal Section
Research Article
Authors
Erdal Bodakçi
*
This is me
Türkiye
Faruk Kılınç
This is me
Türkiye
Mazhar Müslüm Tuna
This is me
Türkiye
Zafer Pekkolay
This is me
Türkiye
Alpaslan Kemal Tuzcu
This is me
Türkiye
Aziz Karabulut
This is me
Türkiye
Publication Date
June 12, 2023
Submission Date
March 22, 2023
Acceptance Date
April 3, 2023
Published in Issue
Year 2023 Volume: 50 Number: 2